I love your attitude and POV on the upswings: confident, positive, contributory intel and insight. The downswings: not so much lol. NP bashing, suspicious, bitter. It makes sense when emotions are tied to the share price and there’s a keyboard to express it, especially if there’s an imminent material need for the cash. These public forums are double-edge swords, and I can’t get a gauge if they have helped the stock more than they’ve hurt it, since the internet is where all the stocks manipulations takes place when bashers and shorts infiltrate boards with disinformation and fear-mongering, and/or draft on the emotional or naive posts of frustrated longs or inexperienced investors.

Leronlimab’s science is solid, and CytoDyn management aren’t dumbies or they never would have gotten it this far, especially given the uphill battle and resistance they have faced from Big Pharma, shorts, and even some of their own shareholders. So the test is simply to buy & hold, and to remain supportive and positive about the prospects of the company getting the drug to its approval in time. Attitude and trust are key. And I get that it can be annoying to need to listen to all the silliness of uniformed weak-hand shareholders, deal with the short attacks (aka buy opps lol), and suffer through the delays and undelivered expectations (small biotech!), and have a love/hate opinion of the CEO, but that’s all part of the test. The only people who deserve the riches of what this stock is truly worth are those who can both hold it and keep their sour tongues (fingers) off the Internet. Shorts love it when they detect doubts within the shareholder community and they will exploit it. Many longs just vent online but don’t actually sell, but the venting triggers shorts which triggers weak-hands to sell en masse. It’s a vicious cycle. Chin up, lips buttons & fingers coiled when scared, trust the science & the company & the process, and hang on as long as you can afford to. Then sell only when you need to spend the cash that’s tied up in the stock.